Tyna discusses the conventional approach to GLP-1 medications, highlighting the aggressive ramp-up strategy often prescribed. She introduces a novel perspective on microdosing these medications, emphasizing their potential benefits for heart and immune health rather than solely for weight loss. This unique approach challenges standard practices and opens the door to exploring lower doses for broader therapeutic effects.
